Exploring lactoferrin as an innovative covalently immobilized chiral selector for the selective separation of pharmaceutical enantiomers using HPLC

IF 6.1 2区 化学 Q1 CHEMISTRY, ANALYTICAL
Analytica Chimica Acta Pub Date : 2026-04-01 Epub Date: 2026-02-05 DOI:10.1016/j.aca.2026.345205
Adel Ehab Ibrahim , Samy G. Alamir , Ghanem Al-Thani , Sami El Deeb , Ahmed Al-Harrasi
{"title":"Exploring lactoferrin as an innovative covalently immobilized chiral selector for the selective separation of pharmaceutical enantiomers using HPLC","authors":"Adel Ehab Ibrahim ,&nbsp;Samy G. Alamir ,&nbsp;Ghanem Al-Thani ,&nbsp;Sami El Deeb ,&nbsp;Ahmed Al-Harrasi","doi":"10.1016/j.aca.2026.345205","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Molecular chirality has a profound impact on pharmaceutical drugs' efficacy and safety. Thus, chiral recognition plays a vital role in drug development throughout all process stages. LF is a globular glycoprotein composed of approximately 700 amino acids, that's capable of providing multiple interactions through its amino acid residues.</div></div><div><h3>Results</h3><div>In the proposed research, lactoferrin (LF) was covalently immobilized for the first time using a monolithic epoxy stationary phase via a Schiff's base formation as chiral selector (CS). LF-CS was evaluated for the enantioselective HPLC separation of 18 racemic pharmaceutical drugs. The chromatographic conditions were optimized for optimum enantio-separation. LF-CS proved its potential as a CS enabling the enantioseparation of 10 drug racemates: cetirizine, omeprazole, lansoprazole, dapoxetine, doxazosin, nebivolol, atenolol, bisoprolol, chlorthalidone and ofloxacin. Moreover, <em>in-silico</em> molecular docking studies were conducted to help understand the separation modes. LF as a CS reported hydrogen bonding, hydrophobic interactions, π bonding, van der Waals forces, and electrostatic interactions. Finally, the novel LF-CS was applied to determine the enantiomeric purity of marketed single-enantiomer pharmaceutical products, demonstrating its ability to verify their composition and identify impurities.</div></div><div><h3>Significance</h3><div>HPLC remains the primary choice for all pharmaceutical research, as it offers higher sensitivity, reliability, and reproducibility. This work introduces LF as a novel, multifunctional CS for HPLC, covalently immobilized for the first time, expanding the toolbox of protein-based chiral stationary phases. Moreover, the study also offers a critical insight into the limitations of relying solely on computational predictions, empirically demonstrating that solvent effects can override binding affinities, a phenomenon not captured by standard docking simulations.</div></div>","PeriodicalId":240,"journal":{"name":"Analytica Chimica Acta","volume":"1393 ","pages":"Article 345205"},"PeriodicalIF":6.1000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analytica Chimica Acta","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003267026001558","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Molecular chirality has a profound impact on pharmaceutical drugs' efficacy and safety. Thus, chiral recognition plays a vital role in drug development throughout all process stages. LF is a globular glycoprotein composed of approximately 700 amino acids, that's capable of providing multiple interactions through its amino acid residues.

Results

In the proposed research, lactoferrin (LF) was covalently immobilized for the first time using a monolithic epoxy stationary phase via a Schiff's base formation as chiral selector (CS). LF-CS was evaluated for the enantioselective HPLC separation of 18 racemic pharmaceutical drugs. The chromatographic conditions were optimized for optimum enantio-separation. LF-CS proved its potential as a CS enabling the enantioseparation of 10 drug racemates: cetirizine, omeprazole, lansoprazole, dapoxetine, doxazosin, nebivolol, atenolol, bisoprolol, chlorthalidone and ofloxacin. Moreover, in-silico molecular docking studies were conducted to help understand the separation modes. LF as a CS reported hydrogen bonding, hydrophobic interactions, π bonding, van der Waals forces, and electrostatic interactions. Finally, the novel LF-CS was applied to determine the enantiomeric purity of marketed single-enantiomer pharmaceutical products, demonstrating its ability to verify their composition and identify impurities.

Significance

HPLC remains the primary choice for all pharmaceutical research, as it offers higher sensitivity, reliability, and reproducibility. This work introduces LF as a novel, multifunctional CS for HPLC, covalently immobilized for the first time, expanding the toolbox of protein-based chiral stationary phases. Moreover, the study also offers a critical insight into the limitations of relying solely on computational predictions, empirically demonstrating that solvent effects can override binding affinities, a phenomenon not captured by standard docking simulations.

Abstract Image

Abstract Image

乳铁蛋白作为新型共价固定化手性选择剂用于药物对映体的高效液相色谱选择性分离
分子手性对药物的疗效和安全性有着深远的影响。因此,手性识别在药物开发的所有过程阶段起着至关重要的作用。LF是一种由大约700个氨基酸组成的球状糖蛋白,能够通过其氨基酸残基提供多种相互作用。结果在本研究中,乳铁蛋白(LF)首次通过席夫碱形成的单片环氧固定相作为手性选择剂(CS)被共价固定。采用高效液相色谱法对18种外消旋药物的对映选择性分离进行了评价。优化了对映体分离的最佳色谱条件。LF-CS证明了其作为CS的潜力,可以对10种药物外消旋物进行对映体分离:西替利嗪、奥美拉唑、兰索拉唑、达泊西汀、多沙唑嗪、奈比洛尔、阿替洛尔、比索洛尔、氯噻酮和氧氟沙星。此外,进行了硅分子对接研究,以帮助了解分离模式。作为CS的LF报道了氢键、疏水相互作用、π键、范德华力和静电相互作用。最后,将新型LF-CS应用于已上市的单对映体药品的对映体纯度测定,证明了其验证成分和杂质鉴定的能力。高效液相色谱法仍然是所有药物研究的首选,因为它具有更高的灵敏度、可靠性和重复性。本文首次介绍了LF作为一种新型的多功能高效液相色谱,共价固定,扩大了基于蛋白质的手性固定相的工具箱。此外,该研究还对仅依靠计算预测的局限性提供了重要的见解,经验证明溶剂效应可以覆盖结合亲和力,这是标准对接模拟无法捕获的现象。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Analytica Chimica Acta
Analytica Chimica Acta 化学-分析化学
CiteScore
10.40
自引率
6.50%
发文量
1081
审稿时长
38 days
期刊介绍: Analytica Chimica Acta has an open access mirror journal Analytica Chimica Acta: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. Analytica Chimica Acta provides a forum for the rapid publication of original research, and critical, comprehensive reviews dealing with all aspects of fundamental and applied modern analytical chemistry. The journal welcomes the submission of research papers which report studies concerning the development of new and significant analytical methodologies. In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and impact of the research and the extent to which it adds to the existing body of knowledge in analytical chemistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书